TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Dishman Carbogen Amcis Ltd. ( (IN:DCAL) ) has provided an update.
Dishman Carbogen Amcis Ltd. has released an investor presentation in compliance with SEBI regulations, which is now available on their website. This move is part of the company’s commitment to transparency and regular communication with stakeholders, potentially impacting investor relations positively.
More about Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Ltd. operates in the pharmaceutical industry, focusing on providing contract research and manufacturing services. The company is known for its expertise in the development and production of active pharmaceutical ingredients (APIs) and intermediates, catering to a global market.
Average Trading Volume: 15,243
Technical Sentiment Signal: Strong Buy
Current Market Cap: 42.86B INR
Find detailed analytics on DCAL stock on TipRanks’ Stock Analysis page.

